Correction to: Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

Detalles Bibliográficos
Autores principales: Stockmann, Julia, Verberk, Inge M. W., Timmesfeld, Nina, Denz, Robin, Budde, Brian, Lange-Leifhelm, Julia, Scheltens, Philip, van der Flier, Wiesje M., Nabers, Andreas, Teunissen, Charlotte E., Gerwert, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809829/
https://www.ncbi.nlm.nih.gov/pubmed/33451318
http://dx.doi.org/10.1186/s13195-021-00770-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809829/
https://www.ncbi.nlm.nih.gov/pubmed/33451318
http://dx.doi.org/10.1186/s13195-021-00770-2

Ejemplares similares